Akero Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AKRO Nasdaq 2830 akerotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akero Therapeutics, Inc.

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Mar 4th, 2025 2:40 pm
Why Akero Therapeutics, Inc. (AKRO) is Skyrocketing So Far in 2025 - Mar 2nd, 2025 2:34 pm
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Feb 28th, 2025 12:00 pm
Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts? - Feb 27th, 2025 6:23 pm
Akero Therapeutics, Inc. (AKRO): the Best Performing Pharma Stock So Far in 2025 - Feb 23rd, 2025 8:18 pm
Akero Therapeutics, Inc. (AKRO): the Best Performing Healthcare Stock So Far in 2025 - Feb 19th, 2025 7:45 pm
Akero Therapeutics Inc. (AKRO): Among The Stocks That Started The Year On A High - Feb 3rd, 2025 5:28 pm
This Stock Just Doubled in 1 Day -- Is It Still a Buy? - Feb 2nd, 2025 11:21 pm
Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now? - Feb 2nd, 2025 9:35 pm
Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jan 30th, 2025 9:05 pm
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics - Jan 30th, 2025 2:55 pm
Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates - Jan 29th, 2025 5:02 pm
AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study - Jan 29th, 2025 3:15 pm
BioAge drops obesity drug; Akero, 89bio cash in on MASH data - Jan 29th, 2025 10:39 am
Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants - Jan 29th, 2025 2:30 am
Akero’s cirrhosis treatment shows promise in Phase IIb study - Jan 28th, 2025 4:14 pm
Why Akero Therapeutics Inc. (AKRO) Surged on Monday - Jan 28th, 2025 1:40 pm
Akero Therapeutics Stock Nearly Doubles — Pulling 89bio Higher — On Positive MASH Study - Jan 27th, 2025 9:24 pm
Akero Therapeutics Announces Proposed Public Offering of Common Stock - Jan 27th, 2025 9:01 pm
Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data - Jan 27th, 2025 5:13 pm